Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s stock price reached a new 52-week low on Thursday . The stock traded as low as $20.50 and last traded at $20.50, with a volume of 270 shares changing hands. The stock had previously closed at $24.25.
Hikma Pharmaceuticals Trading Down 0.0%
The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33. The firm has a 50 day simple moving average of $23.29 and a two-hundred day simple moving average of $25.59.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Further Reading
- Five stocks we like better than Hikma Pharmaceuticals
- Business Services Stocks Investing
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Differences Between Momentum Investing and Long Term Investing
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- What Investors Need to Know About Upcoming IPOs
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
